Unknown

Dataset Information

Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model.


ABSTRACT: Sepsis remains a major public health problem with no major therapeutic advances over the last several decades. The clinical and biological heterogeneity of sepsis have limited success of potential new therapies. Accordingly, there is considerable interest in developing a precision medicine approach to inform more rational development, testing, and targeting of new therapies. We previously developed the Pediatric Sepsis Biomarker Risk Model (PERSEVERE) to estimate mortality risk and proposed its use as a prognostic enrichment tool in sepsis clinical trials; prognostic enrichment selects patients based on mortality risk independent of treatment. Here, we show that PERSEVERE has excellent performance in a diverse cohort of children with septic shock with potential for use as a predictive enri

SUBMITTER: Wong HR 

PROVIDER: S-EPMC7720682 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature